A U.S. lawmaker is taking action after a KHN investigation exposed weaknesses in the federal system meant to stop repeat Medicare and Medicaid fraud and abuse.
Often, drugs granted exclusivity are among the highest priced in the U.S. market.
Get the most out of
Register for free and enjoy unlimited access to: